Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

668 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mimickers of hydroxychloroquine retinal toxicity.
Jones P, Kalra G, Al-Sheikh M, Chhablani J. Jones P, et al. Among authors: chhablani j. Clin Exp Ophthalmol. 2024 Dec;52(9):1003-1015. doi: 10.1111/ceo.14461. Epub 2024 Dec 3. Clin Exp Ophthalmol. 2024. PMID: 39626654 Free PMC article. Review.
Abnormal retinal vessel filling in central retinal artery occlusion.
Venkatesh R, Mangla R, Parmar Y, Chitturi SP, Yadav NK, Chhablani J. Venkatesh R, et al. Among authors: chhablani j. Clin Exp Optom. 2024 Nov;107(8):801-805. doi: 10.1080/08164622.2023.2298781. Epub 2024 Jan 7. Clin Exp Optom. 2024. PMID: 38184849
Choroidal biomarkers in age-related macular degeneration.
Sadeghi E, Valsecchi N, Rahmanipour E, Ejlalidiz M, Hasan N, Vupparaboina KK, Ibrahim MN, Rasheed MA, Baek J, Iannetta D, Chhablani J. Sadeghi E, et al. Among authors: chhablani j. Surv Ophthalmol. 2024 Oct 18:S0039-6257(24)00131-0. doi: 10.1016/j.survophthal.2024.10.004. Online ahead of print. Surv Ophthalmol. 2024. PMID: 39426529 Free article. Review.
A journey through the world of vitreous.
Ayalon A, Sahel JA, Chhablani J. Ayalon A, et al. Among authors: chhablani j. Surv Ophthalmol. 2024 Nov-Dec;69(6):957-966. doi: 10.1016/j.survophthal.2024.06.004. Epub 2024 Jun 15. Surv Ophthalmol. 2024. PMID: 38885759 Review.
Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.
Wiley HE, Srinivasan R, Maranchie JK, Chhablani J, Iversen ABB, Kruse A, Jonasch E, Gombos DS, Else T, Demirci H, Maughan BL, Hartnett ME, Coleman HR, Fu W, Perini RF, Liu Y, Linehan WM, Chew EY; LITESPARK-004 Investigator Group - Ocular VHL. Wiley HE, et al. Among authors: chhablani j. Ophthalmology. 2024 Nov;131(11):1324-1332. doi: 10.1016/j.ophtha.2024.05.024. Epub 2024 Jun 6. Ophthalmology. 2024. PMID: 38849055 Clinical Trial.
Evidence-based guidelines for drug dosing in intravitreal injections in silicone oil-filled eyes: Pharmacokinetics, safety, and optimal dosage.
Ferro Desideri L, Sim PY, Bernardi E, Paschon K, Roth J, Fung AT, Wu XN, Chou HD, Henderson R, Tsui E, Berrocal M, Chhablani J, Wykoff CC, Cheung CMG, Querques G, Melo GB, Subhi Y, Loewenstein A, Kiilgaard JF, Zinkernagel M, Anguita R. Ferro Desideri L, et al. Among authors: chhablani j. Surv Ophthalmol. 2025 Jan-Feb;70(1):96-105. doi: 10.1016/j.survophthal.2024.09.006. Epub 2024 Sep 27. Surv Ophthalmol. 2025. PMID: 39343316 Free article. Review.
668 results